244 related articles for article (PubMed ID: 33475334)
1. Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.
Lum PT; Sekar M; Gan SH; Bonam SR; Shaikh MF
ACS Chem Neurosci; 2021 Feb; 12(3):391-418. PubMed ID: 33475334
[TBL] [Abstract][Full Text] [Related]
2. A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease.
Islam MR; Jony MH; Thufa GK; Akash S; Dhar PS; Rahman MM; Afroz T; Ahmed M; Hemeg HA; Rauf A; Thiruvengadam M; Venkidasamy B
Mol Neurobiol; 2024 Mar; 61(3):1237-1270. PubMed ID: 37698833
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
[TBL] [Abstract][Full Text] [Related]
4. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
Kumar P; Kumar A
J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
[TBL] [Abstract][Full Text] [Related]
5. Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats.
Wells RG; Azzam AF; Hiller AL; Sardinia MF
J Huntingtons Dis; 2024; 13(1):55-66. PubMed ID: 38489193
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
Mehan S; Monga V; Rani M; Dudi R; Ghimire K
Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms.
Lum PT; Sekar M; Seow LJ; Shaikh MF; Arulsamy A; Retinasamy T; Gan SH; Gnanaraj C; Esa NM; Ramachawolran G; Subramaniyan V; Chinni SV; Wu YS
Front Pharmacol; 2023; 14():1189957. PubMed ID: 37521470
[TBL] [Abstract][Full Text] [Related]
8. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.
Katariya R; Mishra K; Sammeta S; Umekar M; Kotagale N; Taksande B
Neurotoxicology; 2024 May; 102():12-28. PubMed ID: 38453033
[TBL] [Abstract][Full Text] [Related]
9. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats.
Ramachandran S; Thangarajan S
Chem Biol Interact; 2016 Aug; 256():25-36. PubMed ID: 27206696
[TBL] [Abstract][Full Text] [Related]
10. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway.
Jamwal S; Kumar P
Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301
[TBL] [Abstract][Full Text] [Related]
11. Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease.
Shehata NI; Abd El-Salam DM; Hussein RM; Rizk SM
PLoS One; 2023; 18(11):e0293660. PubMed ID: 37910529
[TBL] [Abstract][Full Text] [Related]
12. Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.
Badini F; Bayrami A; Mirshekar MA; Shahraki S; Fanaei H
Behav Brain Res; 2024 Mar; 461():114864. PubMed ID: 38220060
[TBL] [Abstract][Full Text] [Related]
13. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
Sharma P; Kumar M; Bansal N
Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1917-1928. PubMed ID: 34061228
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Pinene Alleviates Motor Activity in Animal Model of Huntington's Disease via Enhancing Antioxidant Capacity.
Rahmani H; Moloudi MR; Hashemi P; Hassanzadeh K; Izadpanah E
Neurochem Res; 2023 Jun; 48(6):1775-1782. PubMed ID: 36689085
[TBL] [Abstract][Full Text] [Related]
15. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
Hariharan A; Shetty S; Shirole T; Jagtap AG
Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.
Ramachandran S; Thangarajan S
Metab Brain Dis; 2018 Oct; 33(5):1459-1470. PubMed ID: 29855977
[TBL] [Abstract][Full Text] [Related]
17. A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
Fotoohi A; Moloudi MR; Hosseini S; Hassanzadeh K; Feligioni M; Izadpanah E
Neurochem Res; 2021 Jun; 46(6):1372-1379. PubMed ID: 33611726
[TBL] [Abstract][Full Text] [Related]
18. Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.
Malik J; Karan M; Dogra R
Pharm Biol; 2017 Dec; 55(1):980-990. PubMed ID: 28164735
[TBL] [Abstract][Full Text] [Related]
19. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
Thangarajan S; Ramachandran S; Krishnamurthy P
Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
[TBL] [Abstract][Full Text] [Related]
20. Anti-Huntington's Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents.
Afzal M; Sayyed N; Alharbi KS; Alzarea SI; Alshammari MS; Alomar FA; Alenezi SK; Quazi AM; Alzarea AI; Kazmi I
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
